Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

YARROW BIOSCIENCE, INC. (YARW) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

YARROW BIOSCIENCE, INC. (YARW), most recent 12 months reported: revenue $570K, net loss $26.48M, free cash flow -$33.12M. Latest balance sheet on file: liquid cash $22.93M. From SEC filings. Others in Pharmaceutical Preparations: BioXcel Therapeutics, Inc. · RALLYBIO CORPORATION · Onconetix, Inc. · Silence Therapeutics plc · Quantum Cyber N.V. · MEREO BIOPHARMA GROUP PLC · Can-Fite BioPharma Ltd. · PROVECTUS BIOPHARMACEUTICALS, INC.

Stock screener

Watchlist